| Financial Year |
March 31 2023 |
| Monetary Funds |
240,111,355.22 |
| Held-for-trading Financial Assets |
51,250,982.97 |
| Notes Receivable |
96,368,702.72 |
| Accounts Receivable |
500,190,507.84 |
| Advances to Suppliers |
4,868,740.06 |
| Other Receivables |
35,034,283.27 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
460,604,575.39 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
18,744,959.03 |
| Total Current Assets |
1,460,529,104.18 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
19,063,314.43 |
| Investment Properties |
27,414,872.84 |
| Fixed Assetes |
415,590,522.44 |
| Under-construction Projects |
573,606.16 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
14,499,613.29 |
| R&D expenses |
-- |
| Goodwill |
7,645,717.49 |
| Long-Term Deferred and Prepaid Expenses |
7,097,847.78 |
| Deferred Income Tax Assets |
27,893,837.90 |
| Other Non-Current Assets |
191,458,340.49 |
| Sub-Total of Non-Current Assets |
727,714,961.92 |
| Total Assets |
2,188,244,066.10 |
| Short-Term Loans |
26,082,915.72 |
| Trading Financial liabilities |
-- |
| Notes Payable |
140,320,054.04 |
| Accounts Payable |
289,394,870.19 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
34,322,222.73 |
| Taxes Payable |
17,360,261.50 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
78,486,686.57 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
31,069,261.80 |
| Other Current Liabilities |
584,352.31 |
| Sub-Total of Current Liabilities |
622,115,642.57 |
| Long-term Loans |
270,100,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
471,283.10 |
| Sub-Total of Non-Current Liabilities |
276,367,980.92 |
| Total Liabilities |
898,483,623.49 |
| Paid-In Capital(Or Share Stock) |
309,100,000.00 |
| Capital Surplus |
365,393,318.04 |
| Surplus Reserve |
105,542,292.34 |
| LESS:Treasury Stock |
95,768,213.53 |
| Undistributed Profits |
591,166,742.56 |
| Minority Stockholder's Interest |
14,137,560.32 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,275,622,882.29 |
| Owner's Equity（Stockholder's Equity） |
1,289,760,442.61 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,188,244,066.10 |
